Dopamine releases endothelium-derived relaxing factor via α2-adrenoceptors in canine vessels: Comparisons between femoral arteries and veins

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 9, 1998, Pages 669-675

  Segawa, Tomonori ^a   Ito, Hiroyasu ^b   Inoue, Kiyoaki ^a   Wada, Hisayasu ^a   Minatoguchi, Shinya ^a   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY   (Japan)

^b Sawada Hospital   (Japan)

Author keywords

Artery; Dopamine; Endothelium derived relaxing factor; Vein; 1 Adrenoceptor; 2 Adrenoceptor

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; DOPAMINE; ENDOTHELIUM DERIVED RELAXING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOG; DOPAMINE RELEASE; FEMORAL ARTERY; FEMORAL VEIN; NONHUMAN; PRESSOR RESPONSE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VEIN;

EID: 0031691360     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02274.x     Document Type: Article

References (29)

1. McDonald Jr RH, Goldberg LI. Analysis of the cardiovascular effects of dopamine in the dog. J. Pharmacol. Exp. Ther. 1963; 140: 60-6.
2. Toda N, Miyazaki M, Okumura T. Alpha-adrenoceptor subtypes responsible for dopamine-induced mesenteric vein contraction. Jpn. J. Pharmacol. 1984; 36: 253-5.
3. 2-adrenoceptors in the mesenteric bed of the dog. Br J. Pharmacol. 1983; 75 (Suppl.): P73.
4. Goldberg LI. Cardiovascular and renal actions of dopamine: Potential clinical applications. Pharmacol. Rev. 1972; 24: 1-29.
5. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
6. Cocks TM, Angus JA. Endothelium-dependent relaxation of coronary arteries by norepinephrine and serotonin. Nature 1983; 305: 627-30.
7. 2-Adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br. J. Pharmacol. 1986; 88: 767-77.
8. 2-adrenoceptors in canine pulmonary and systemic blood vessels. Eur. J. Pharmacol. 1985; 118: 123-9.
9. Clark AJ. The mode of action of drugs on cells. Edward Arnold and Co., London. 1933.
10. Yang WN, Nelson BL. Using common random numbers and control variates in multiple-comparison procedures. Ope. Res. 1991; 39: 583-91.
11. Toda N. Alpha-adrenoceptor subtypes in human, monkey, and dog cerebral arteries. J. Pharmacol. Exp. Ther. 1983; 226: 861-8.
12. Starke K. α-Adrenoceptor subclassification. Rev. Physiol. Biochem. Pharmacol. 1981; 88: 199-236.
13. 2-adrenoceptor in man. Circ. Res. 1984; 54: 447-52.
14. 2-adrenoceptor. Trends Pharmacol. Sci. 1982; 3: 400-44.
15. Shoji T, Tsuru H, Shigei T. A regional difference in the distribution of postsynaptic alpha-adrenoceptor subtypes in canine veins. Naunyn Schmiedebergs Arch. Pharmacol. 1983; 324: 246-55.
16. 2-like adrenoceptors in canine arterial and venous smooth muscle. Circ. Res. 1981; 48: 875-84.
17. Flavahan NA, Vanhoutte PM. Alpha-1 and alpha-2 adrenoceptor: Response coupling in canine saphenous and femoral veins. J. Pharmacol. Exp. Ther. 1984; 238: 131-8.
18. Langer SZ, Hicks PE. Alpha-adrenoceptor subtypes in blood vessels: Physiology and pharmacology. J. Cardiovasc. Pharmacol. 1984; 6 (Suppl. 4): S547-58.
19. Trendelenburg U, Langeloh A, Bönisch H. Mechanism of action of indirectly acting sympathomimetic amines. Blood Vessels 1987; 24: 261-70.
20. Goodman AG, Goodman LS, Gilman A (eds). Catecholamines. In: The Pharmacological Basis of Therapeutics, 9th edn. MacMillan Publishing, New York, 1996: Ch. 6.
21. Parent R, Al-Obaidi M, Lavallee M. Nitric oxide formation contributes to β-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ. Res. 1993; 73: 241-51.
22. Bea ML, Ghaleh B, Guidicelli JF, Berdeaux A. Lack of importance of NO in β-adrenoceptor-mediated relaxation of large epicardial canine coronary arteries. Br. J. Pharmacol. 1994; 111: 981-2.
23. Quillen J, Sellke F, Banitt P, Harrison D. The effect norepinephrine on the coronary microcirculation. J. Vasc. Res. 1992; 29: 2-7.
24. McNay JL, McDonald Jr RH, Goldberg LI. Direct renal vasodilatation produced by dopamine in the dog. Circ. Res. 1965; 16: 510-17.
25. McNay JL, Goldberg LI. Comparison of effect of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal amd femoral blood flow. J. Pharmacol. Exp. Ther. 1966; 151: 23-31.
26. 2. Circ. Res. 1978; 9: 384-9.
27. Toda N, Imbs JL, Schwartz (eds). Dopamine-induced relaxation of isolated dog arteries. In: Advances in the Biosciences, Vol. 20. Pergamon Press, Oxford. 1979; 135-41.
28. Toda N, Hashimoto Y. Antagonism by doroperidol of dopamine-induced relaxation in isolated dog arteries. Eur. J. Pharmacol. 1979; 59: 231-8.
29. Hirakawa S, Ito H, Kotoo Y, Abe C, Endo T, Fuseno H. The role of alpha and beta adrenergic receptors in constriction and dilation of the systemic capacitance vessels: A study with the measurements of the mean circulatory pressure in dogs. Jpn. Circ. J. 1984; 48: 620-32.